Search results
23andMe CEO Says Company Is Doing Fine Despite Losing 93% of Stock Value
Futurism via Yahoo News· 4 months agoThe consumer genome sequencing company 23andMe is a sinking ship – and their CEO is playing the...
3 Gene Sequencing Stocks With Potential to Gain in 2H22
Zacks via Yahoo Finance· 2 years agoThe first half of 2022 was marred by a decline in stocks across all industries with the rise in...
Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics
Zacks via Yahoo Finance· 5 months agoQuest Diagnostics DGX recently announced a collaboration with Ultima Genomics, the developer of the...
Illumina and Best Buy have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – August 1, 2022 – Zacks Equity Research shares Illumina ILMN as...
Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger
Zacks via Yahoo Finance· 1 year agoIllumina’s ILMN market opportunities continue to expand owing to accelerated demand from clinical...
PacBio's (PACB) Latest Offering to Enhance Genome Sequencing
Zacks via Yahoo Finance· 2 years agoPacBio's (PACB) latest sequencing panels are expected to simplify the study of the...
QIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit
Zacks via Yahoo Finance· 2 weeks agoQIAGEN N.V. QGEN recently announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit...
Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled...
Motley Fool· 1 year agoAfter a blistering start to the year, small-cap biotech stocks made a U-turn in the second week of...
QIAGEN (QGEN) Launches Workflow to Boost Microbiome Research
Zacks via Yahoo Finance· 7 months agoQIAGEN N.V. QGEN recently announced the launch of the Microbiome WGS (whole-genome sequencing)...
Inside Illumina’s $8 billion deal that spurred a proxy fight with Carl Icahn and the ouster of 2...
Fortune via Yahoo Finance· 11 months agoThe idea that a simple blood test could detect early cancer in a healthy person has always seemed...